<DOC>
	<DOCNO>NCT02874378</DOCNO>
	<brief_summary>Postoperative renal function recovery important value operation quality kidney transplantation . Dexmedetomidine selective alpha-2 agonist , enhance urine flow rate perioperative renal function . Some animal experiment reveal beneficial effect ischemia-reperfusion injury ( IRI ) , goal therefore investigate effectiveness recipient treatment Dexmedetomidine operation reduce Cystatin C level enhance renal function kidney transplantation .</brief_summary>
	<brief_title>Effects Dexmedetomidine Postoperative Renal Function Recovery After Kidney Transplantation Adult Patients</brief_title>
	<detailed_description>Participants randomly assign , 1:1 ratio , receive Dexmedetomidine control ( 0.9 % Sodium Chloride Solution,0.9 % NaCl ) . The randomization sequence computer-generated , randomization perform block stratify accord participate center.Dexmedetomidine 0.9 % NaCl solution treat 10 minute anesthesia induction , end last 10 minute operation complete . Cystatin C level urine volume ( limited data ) 1,7,14 day transplantation record . The participation patient schedule 14 days.Investigators research live cadaveric kidney transplant .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients underwent renal transplant First Affiliated Hospital Xi'an Jiaotong University . severe comorbidity history : severe cardiac dysfunction , central nervous system disease , endocrine , history mental disorder ; alcoholic longterm use sedatives opioids history ; drug allergy history .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>